Macro Insights

Paris, 19/06/17

 

Political cycle ends in France; UK to start Brexit negotiations

 

 

  • All eyes on US policies and Fed speakers; political cycle ends in France with majority for President Macron while the UK enters a pivotal week.
  • Policy and Fed speakers at centre stage. US Congress will remain busy and the Senate is trying to draft a healthcare bill before the 4 July Congressional Recess. The success or otherwise of this will be important in determining whether the Republicans can “repeal and replace” Obamacare. In the fiscal space, the prospect of interest deductibility is drawing more attention as ‘border tax adjustability’ (BAT) appears an ever more distant prospect. That said, many oppose the prospect of interest deductibility and even if included, there are likely to be significant exemptions (small businesses, utilities and real estate). After last week’s disappointing inflation print (core CPI fell in May to +1.7%yoy from +1.9%), we will watch for Fed participants’ comments as they emerge from the rate-setting purdah period.
  • The UK is due to start negotiations with the EU over Brexit this week. No formal change of direction has been indicated by the government, but there are plenty of calls (from within and outside the government) for a softer separation to be pursued. Meanwhile PM Theresa May continues to face doubts about her future as she struggles to assert herself against a backdrop of successive tragedies engulfing the UK. Elsewhere a light economic calendar will see focus on Governor Carney’s (breakfast) Mansion House speech on Tuesday, with markets seeking clues as to whether the Governor will suggest any signs of joining three dissenting Committee members that voted for an immediate rate hike last week.  
  • Comfortable majority in the Lower House for Emmanuel Macron. La République En Marche ! (LREM) and its allies from Modem (centre-right) got 350 seats out of 577 and will be able to push forward President Macron’s reformist agenda. Looking forward, LREM will look to secure more seats in the Senate (Upper House), which half will be renewed in September and where LR currently have a majority.
  • Chinese economy holds steady; we revise down our CNY/USD forecast (less deprecation) to account for recent RMB stability. Economic momentum appears to be well preserved in May after some leakage from Q1. Despite this stability, we continue to expect the economy to slow gradually in the second half of the year, thanks to policy tightening on the housing market and financial system. Beijing will ensure the operation is carefully managed to avoid disruptions ahead of the Party Congress. Recent RMB appreciation, following a period of stability, has dispelled depreciation expectations.
  • EMs: Different issues, different monetary policies. The Bank of Russia cut its key interest rate by 25bp to 9% at its 16 June meeting, having signalled earlier that the cut would be higher at 50bp (which also matched our call). We attribute this change in hearts to the worsening external backdrop of lower oil prices weighing on the currency and sanctions news flow affecting sentiment. The central bank of Mexico is expected to deliver its last 25bp rate hike at its monetary policy meeting on 22 June, render the policy rate 7% and take a pause till year-end as inflation is showing signs of abating.

Events coming up:

UK: Governor Carney’s Mansion House speech (Tuesday), Queen’s Speech (Wednesday), beginning of Brexit negotiations

Euro area data: EMU June PMI (Friday)

EMs: MPC of the Bank of Mexico (Thursday)

Market and asset types measured by the following indices: Equities = MSCI. Fixed Income = JP Morgan and BofAML. 

 

The Research & Investment Strategy (R&IS) team at AXA Investment Managers present their views on recent developments and the factors shaping markets over the week ahead. For more information on the R&IS team or any of the above comments, please contact us or follow us on social media for updates throughout the week

 


DISCLAIMER

This document is used for informational purposes only and does not constitute, on AXA Investment Managers part, an offer to buy or sell, solicitation or investment advice. It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date. Due to the subjective and indicative aspect of these analyses, we draw your attention to the fact that the effective evolution of the economic variables and values of the financial markets could be significantly different from the indications (projections, forecast, anticipations and hypothesis) which are communicated in this document. Furthermore, due to simplification, the information given in this document can only be viewed as subjective. This document may be modified without notice and AXA Investment Managers may, but shall not be obligated, update or otherwise revise this document.

All information in this document is established on data given made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document. Furthermore, due to the subjective nature of these analysis and opinions, these data, projections, forecasts, anticipations, hypothesis and/or opinions are not necessary used or followed by AXA IM' management teams or its affiliates who may act based on their own opinions and as independent departments within the Company. By accepting this information, the recipients of this document agrees that it will use the information only to evaluate its potential interest in the strategies described herein and for no other purpose and will not divulge any such information to any other party. Any reproduction of this information, in whole or in part, is unless otherwise authorised by AXA IM prohibited.

Editor : AXA INVESTMENT MANAGERS, a company incorporated under the laws of France, having its registered office located at Cœur Défense Tour B La Défense 4, 100, Esplanade du Général de Gaulle 92400 Courbevoie, registered with the Nanterre Trade and Companies Register under number 393 051 826.

© AXA Investment Managers 2015